Treatment of brain metastases in patients with testicular cancer

Journal of Clinical Oncology

Volumn 15, Issue 4, 1997, Pages 1449-1454

  Bokemeyer, C ^a   Nowak, P ^a   Haupt, A ^a   Metzner, B ^a   Kohne H ^a   Hartmann, J T ^a   Kanz, L ^a   Schmoll, H J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; VINBLASTINE; VINCA ALKALOID; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; INTRATHECAL DRUG ADMINISTRATION; LUNG METASTASIS; MALE; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEMINOMA; TESTIS CANCER; TREATMENT OUTCOME;

EID: 0030960493     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.4.1449     Document Type: Article

References (27)

1. Einhorn LH: Treatment of testicular cancer: A new improved model. J Clin Oncol 11:1777-1778, 1990
2. Peckham MJ, Barren A, Liew KH, et al: The treatment of metastatic germ-cell testicular tumors with bleomycin, etoposide and cis-platin (BEP). Br J Cancer 47:613-619, 1983
3. Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ cell tumors with cisplatin, bleomycin, and either vinblastin or etoposide. N Engl J Med 316:1435-1440, 1987
4. Birch R, Williams S, Cone A, et al: Prognostic factors for favourable outcome in disseminated germ cell tumors. J Clin Oncol 4:400-407, 1986
5. Bosl GJ, Geller NL, Cirrincone C, et al: Multivariate analysis of prognostic variable in patients with metastatic testicular cancer. Cancer Res 43:3403-3407, 1983
6. The Medical Research Council Working Party on Testicular Tumours: Prognostic factors in advanced non-seminomatous germcell testicular tumours: Results of a multicenter study. Lancet 1:8-11, 1985
7. Higi M, Scheulen ME, Schmidt CG, et al: Brain metastases in malignant testicular teratomas (Hirnmetastasen bei malignen Hodenteratomen). Onkologie 4:84-86, 1981
8. Lester SG, Morphis JG, Hornback NB, et al: Brain metastases and testicular tumors: Need for aggressive therapy. J Clin Oncol 2:1397-1403, 1984
9. Stolinsky DC: Prolonged survival after cerebral metastasis of testicular carcinoma. Cancer 47:978-981, 1981
10. Williams SD, Einhorn LH: Brain metastases in disseminated germinal neoplasms, incidence and clinical course. Cancer 44:1514-1516, 1979
11. Spears T, Morphis G, Lester G, et al: Brain metastases and testicular tumors: Long-term survival. Int J Radiat Oncol Biol Phys 22:17-22, 1991
12. Clemm Ch, Gerl A, Wendt TG, et al: Derzeitiger Stand der Therapie von ZNS-Metastasen bei Keimzelltumoren. Urologe [A] 32:217-224, 1993
13. Gerl A, Clemm Ch, Kohl P, et al: Central nervous system as sanctuary site of relapse in patients treated with chemotherapy for metastatic testicular cancer. Clin Exp Metastasis 12:226-230, 1994
14. Logothetis CJ, Samuels ML, Trindade A: The management of brain metastases in germ cell tumors. Cancer 49:12-18, 1982
15. Raghavan D, Mackintosh JF, Fox RM, et al: Improved survival after brain metastases in non-seminomatous germ cell tumours with combined modality treatment. Br J Urol 60:364-367, 1987
16. Bokemeyer C, Schmoll HJ, Harstrick A, et al: A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamid plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours. Eur J Cancer 29A:2255-2231, 1993
17. Harstrick A, Schmoll HJ, Wilke H, et al: Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsed germ cell carcinoma. J Clin Oncol 9:1549-1555, 1991
18. Loehrer PJ, Einhorn LH, Williams SD: VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer. J Clin Oncol 4:528-536, 1986
19. Raina V, Singh SP, Kamble N, et al: Brain metastases as the site of relapse in germ cell tumor of testis. Cancer 72:2182-2185, 1993
20. Nichols CR: Management of central nervous system metastases in patients with disseminated germ cell tumours, in Jones WG, Harnden P, Appleyard I (eds): Advances in the Biosciences, vol 91. Oxford, UK, Elsevier Science, 1994, p 251
21. Rustin JS, Newlands S, Bagshawe KD, et al: Successful management of metastatic and primary germ cell tumors in the brain. Cancer 57:2108-2113, 1986
22. Rustin JS, Newlands S, Begent RH, et al: Weekly alternating etoposide, methotrexate, and actinomycin/vincristin and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. J Clin Oncol 7:900-903, 1989
23. Fossa SD: Treatment of cerebral metastases from malignant germ cell tumours, in Jones WG. Harnden P. Appleyard I (eds): Advances in the Biosciences, vol 91. Oxford, UK, Elsevier Science, 1994, p 249
24. O'Reilly SM, Rustin GJS, Newlands ES: Treatment of central nervous system (CNS) metastases of non-seminomatous germ cell tumours, in Jones WG, Harnden P, Appleyard I (eds): Advances in the Biosciences, vol 91. Oxford, UK, Elsevier Science, 1994, p 247
25. Kobayashi T, Yoshida J, Ishiyama J: Combination chemotherapy with cisplatin and etoposide for malignant intracranial germ cell tumors. J Neurosurg 70:676-681, 1989
26. Siegal T, Pfeffer MR, Catane R, et al: Successful chemotherapy of recurrent intracranial germinoma with spinal metastases. Neurology 33:631-633, 1983
27. Kaye SB, Bagshawe KD, McElwain TJ, et al: Brain metastases in malignant teratoma: A review of four years experience and an assessment of the role of tumour markers. Br J Cancer 39:217-223, 1979